Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome DrugDecember 02, 2024 8:00 AM EST | Source: Ainos, Inc.San Diego, California--(Newsfile Corp. - December 2, 2024) - Ainos, Inc. (NASDAQ: AIMD) (NASDAQ: AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") and low-dose interferon therapeutics, today proudly announced the signi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from____to____ Commission File No. 001-41461 AINOS, INC. (Exact name of registrant as specified in its charter) | --- | --- | --- | |-------------------------- ...

AI Nose now has a 79% accuracy in identifying 761 samples across 22 VOCs in Japanese semiconductor manufacturing factories AI Nose can be integrated into robotics systems in smart factories, serving as the digital nose of AI technology SAN DIEGO, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and VELDONA low-dose interferon therapeutics, today announced that its ...

Ainos (NASDAQ:AIMD) stock is heading higher on Monday after the medical technologies development company secured new patent licenses.According to a press release from Ainos, the company has obtained exclusive licenses for 10 patents from Taiwan Carbon Nano Technology. This is Ainos’ affiliate and product co-developer.Ainos notes that the patents in this agreement are tied to gas sensors and medical devices. These patents cover multiple regions including the U.S., Germany, China, Japan and Taiwan.The company ...

Exhibit 99.1 Ainos Reports Second Quarter 2024 Financial Results Enrolling first subject for FCGS clinical study marks a solid start in shifting animal health emphasis to drug developments Robust financial runway for over 12 months following the prepayment of a senior secured convertible note SAN DIEGO, CA / ACCESSWIRE /August 5, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and low-dose interf ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from____to____ Commission File No. 001-41461 AINOS, INC. (Exact name of registrant as specified in its charter) | --- | --- | |-----------------------------------|- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from____to____ Commission File No. 001-41461 AINOS, INC. (Exact name of registrant as specified in its charter) TEXAS 75-1974352 (State or other jurisdiction (IRS ...

Exhibit 99.1 Ainos Reports First Quarter 2024 Financial Results Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024 US$9M growth capital secured in May strengthens financial position for executing growth strategy SAN DIEGO, May 13, 2024 /Accesswire/ — Ainos, Inc. (NASDAQ: AIMD, AIMDW) (“Ainos”, or the “Company”), a diversified healthcare company focused on the development of novel point-of-care testing (“POCT”), low-dose interferon therapeutics, and synthetic RNA-driven pre ...

Ainos (NASDAQ:AIMD) stock is rocketing higher on Friday with heavy trading of the healthcare company’s shares.This has more than 7 million shares of the company’s stock changing hands as of this writing. That’s already well above its daily average trading volume of about 978,000 shares.It’s worth mentioning that this movement comes without any clear news from the company. That means there are no press releases or filings that explain why the stock is up today.One thing that investors will want to note is th ...

U.S. Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2023 ☐ Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from _________ to _________ Commission File Number 001-41461 AINOS, INC. (Exact name of registrant as specified in its charter) Texas 75-1974352 (State or other jurisdiction of incorpora ...